Result of AGM
TheraCryf plc announced that all resolutions were duly passed at its Annual General Meeting held on October 22, 2026. The company, which is developing new medicines for addiction and neuropsychiatric disorders, confirmed that voting results will be available on its website. This positive outcome regarding governance matters is generally viewed favorably by investors.
Select text to share a quote on X · sign in to keep highlights & notes in your TCF notes
TheraCryf plc, the biotech company developing new medicines for addiction and other neuropsychiatric disorders, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.
The AGM voting results will be available on the Company's website here.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.